series-c-plus
Stage
2
Investors
About
NanoPhoria Bioscience is a preclinical-stage biotechnology company pioneering next generation cardiovascular treatments through an innovative inhaled Nano-in-Micro delivery platform targeting heart failure with reduced ejection fraction (HFrEF).
Explore NanoPhoria's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.